Clinical Trial Update: Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 results from a study of spartalizumab combinations in previously treated unresectable or metastatic melanoma have been posted. The trial is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Spartalizumab (spartalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-01-18